Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Rigel Pharmaceuticals, Inc. (RIGL) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Rigel Pharmaceuticals, Inc. (RIGL) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for November 22nd
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 22:
BrainsWay Ltd. (BWAY - Free Report) : This commercial stage medical device company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.6% over the last 60 days.
Brainsway Ltd. Sponsored ADR Price and Consensus
Brainsway Ltd. Sponsored ADR price-consensus-chart | Brainsway Ltd. Sponsored ADR Quote
BrainsWay's shares gained 52.3% over the last three months compared with the S&P 500’s advance of 2.4%. The company possesses a Momentum Score of B.
Brainsway Ltd. Sponsored ADR Price
Brainsway Ltd. Sponsored ADR price | Brainsway Ltd. Sponsored ADR Quote
Rigel Pharmaceuticals, Inc. (RIGL - Free Report) : This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.9% over the last 60 days.
Rigel Pharmaceuticals, Inc. Price and Consensus
Rigel Pharmaceuticals, Inc. price-consensus-chart | Rigel Pharmaceuticals, Inc. Quote
Rigel Pharmaceuticals' shares gained 11.1% over the last one month compared with the S&P 500’s advance of 7.4%. The company possesses a Momentum Score of B.
Rigel Pharmaceuticals, Inc. Price
Rigel Pharmaceuticals, Inc. price | Rigel Pharmaceuticals, Inc. Quote
Dutch Bros Inc. (BROS - Free Report) : This drive-thru franchise company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40% over the last 60 days.
Dutch Bros Inc. Price and Consensus
Dutch Bros Inc. price-consensus-chart | Dutch Bros Inc. Quote
Dutch Bros’ shares gained 16.7% over the last one month compared with the S&P 500’s advance of 7.4%. The company possesses a Momentum Score of A.
Dutch Bros Inc. Price
Dutch Bros Inc. price | Dutch Bros Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.